Dupixent Invest Information

Pharmaceuticals
Dupixent Receives CHMP Endorsement for Pediatric Eosinophilic Esophagitis Treatment in the EU Sep 21, 2024
Pharmaceuticals
Dupixent® (dupilumab) Receives U.S. Approval for Treating Chronic Rhinosinusitis with Nasal Polyps in Adolescents Sep 14, 2024
Pharmaceuticals
Regeneron Showcases Respiratory Treatments at ERS 2024 Congress Aug 26, 2024
Pharmaceuticals
Innovative COPD Therapy Dupixent Gains Approval in the EU, Marking a First for Targeted Treatment Jul 4, 2024
Pharmaceuticals
Sanofi’s Dupixent Under FDA Priority Review for Adolescents with CRSwNP May 14, 2024